drugset / Trial / NCT05665699
Phase II Study to Evaluate Efficacy and Safety of D-0120 in Combination With Allopurinol in Subjects With Gout
RandomizedParallel-groupOpen-labelTreatment
Summary
D-0120 is being tested in combination with Allopurinol in adult subjects with Gout.
Timeline
- Start
- 2023-04-17
- Primary completion
- 2025-07-31
- Completion
- 2025-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | D-0120 | Unknown | — | — |
| Background | Allopurinol | Small molecule | — | — |